IDEXX LABORATORIES INC /DE Cost of Revenue
IDEXX LABORATORIES INC /DE (IDXX) reported Cost of Revenue of $375.05 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-01.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2025-05-01
- IDEXX LABORATORIES INC /DE cost of revenue for the quarter ending 2025-03-31 was $375.05M, a 1.08% increase year-over-year.
- IDEXX LABORATORIES INC /DE cost of revenue for the quarter ending 2024-09-30 was $379.50M, a 3.25% increase year-over-year.
- IDEXX LABORATORIES INC /DE cost of revenue for the quarter ending 2024-06-30 was $384.42M, a 3.68% increase year-over-year.
- IDEXX LABORATORIES INC /DE cost of revenue for the quarter ending 2024-03-31 was $371.02M, a 3.86% increase year-over-year.
- IDEXX LABORATORIES INC /DE cost of revenue for fiscal 2023 was $1.47B, a 7.92% increase from fiscal 2022.
- IDEXX LABORATORIES INC /DE cost of revenue for fiscal 2022 was $1.36B, a 2.79% increase from fiscal 2021.
- IDEXX LABORATORIES INC /DE cost of revenue for fiscal 2021 was $1.33B, a 16.76% increase from fiscal 2020.
- IDEXX LABORATORIES INC /DE cost of revenue for fiscal 2020 was $1.14B, a 9.05% increase from fiscal 2019.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2025-03-31 | $375.05M 10-Q · filed 2025-05-01 | |||
| 2024-09-30 | $379.50M 10-Q · filed 2024-10-31 | $763.92M derived: sum of 2 quarters · filed 2024-10-31 | $1.13B 10-Q · filed 2024-10-31 | $1.51B derived: sum of 4 quarters · filed 2025-05-01 |
| 2024-06-30 | $384.42M 10-Q · filed 2024-08-06 | $755.44M 10-Q · filed 2024-08-06 | $1.13B derived: sum of 3 quarters · filed 2025-05-01 | $1.50B derived: sum of 4 quarters · filed 2025-05-01 |
| 2024-03-31 | $371.02M 10-Q · filed 2025-05-01 | $746.46M derived: sum of 2 quarters · filed 2025-05-01 | $1.11B derived: sum of 3 quarters · filed 2025-05-01 | $1.48B derived: sum of 4 quarters · filed 2025-05-01 |
| 2023-12-31 | $375.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $742.98M derived: sum of 2 quarters · filed 2024-10-31 | $1.11B derived: sum of 3 quarters · filed 2024-10-31 | $1.47B 10-K · filed 2024-02-22 |
| 2023-09-30 | $367.55M 10-Q · filed 2024-10-31 | $738.33M derived: sum of 2 quarters · filed 2024-10-31 | $1.10B 10-Q · filed 2024-10-31 | $1.44B derived: sum of 4 quarters · filed 2024-10-31 |
| 2023-06-30 | $370.78M 10-Q · filed 2024-08-06 | $728.00M 10-Q · filed 2024-08-06 | $1.07B derived: sum of 3 quarters · filed 2024-08-06 | $1.41B derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $357.22M 10-Q · filed 2024-05-01 | $700.87M derived: sum of 2 quarters · filed 2024-05-01 | $1.04B derived: sum of 3 quarters · filed 2024-05-01 | $1.38B derived: sum of 4 quarters · filed 2024-05-01 |
| 2022-12-31 | $343.64M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $678.68M derived: sum of 2 quarters · filed 2024-02-22 | $1.03B derived: sum of 3 quarters · filed 2024-02-22 | $1.36B 10-K · filed 2024-02-22 |
| 2022-09-30 | $335.04M 10-Q · filed 2023-11-01 | $681.55M derived: sum of 2 quarters · filed 2023-11-01 | $1.02B 10-Q · filed 2023-11-01 | $1.36B derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $346.51M 10-Q · filed 2023-08-01 | $684.31M 10-Q · filed 2023-08-01 | $1.03B derived: sum of 3 quarters · filed 2024-02-22 | $1.37B derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $337.80M 10-Q · filed 2023-05-02 | $682.47M derived: sum of 2 quarters · filed 2024-02-22 | $1.02B derived: sum of 3 quarters · filed 2024-02-22 | $1.36B derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $344.67M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $682.17M derived: sum of 2 quarters · filed 2024-02-22 | $1.02B derived: sum of 3 quarters · filed 2024-02-22 | $1.33B 10-K · filed 2024-02-22 |
| 2021-09-30 | $337.50M 10-Q · filed 2022-11-01 | $674.33M derived: sum of 2 quarters · filed 2022-11-01 | $981.26M 10-Q · filed 2022-11-01 | $1.29B derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | $336.83M 10-Q · filed 2022-08-02 | $643.76M 10-Q · filed 2022-08-02 | $955.20M derived: sum of 3 quarters · filed 2023-02-16 | $1.25B derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | $306.93M 10-Q · filed 2022-05-04 | $618.36M derived: sum of 2 quarters · filed 2023-02-16 | $917.54M derived: sum of 3 quarters · filed 2023-02-16 | $1.18B derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | $311.44M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | $610.62M derived: sum of 2 quarters · filed 2023-02-16 | $868.87M derived: sum of 3 quarters · filed 2023-02-16 | $1.14B 10-K · filed 2023-02-16 |
| 2020-09-30 | $299.18M 10-Q · filed 2021-11-02 | $557.43M derived: sum of 2 quarters · filed 2021-11-02 | $824.18M 10-Q · filed 2021-11-02 | $1.10B derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | $258.25M 10-Q · filed 2021-07-30 | $525.00M 10-Q · filed 2021-07-30 | $799.29M derived: sum of 3 quarters · filed 2022-02-16 | $1.06B derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | $266.75M 10-Q · filed 2021-05-04 | $541.04M derived: sum of 2 quarters · filed 2022-02-16 | $801.40M derived: sum of 3 quarters · filed 2022-02-16 | $1.06B derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | $274.30M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $534.65M derived: sum of 2 quarters · filed 2022-02-16 | $796.90M derived: sum of 3 quarters · filed 2022-02-16 | $1.04B 10-K · filed 2022-02-16 |
| 2019-09-30 | $260.35M 10-Q · filed 2020-10-29 | $522.60M derived: sum of 2 quarters · filed 2020-10-29 | $767.06M 10-Q · filed 2020-10-29 | $1.02B derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-06-30 | $262.25M 10-Q · filed 2020-07-31 | $506.71M 10-Q · filed 2020-07-31 | $755.73M derived: sum of 3 quarters · filed 2021-02-12 | $995.54M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-03-31 | $244.46M 10-Q · filed 2020-04-30 | $493.48M derived: sum of 2 quarters · filed 2021-02-12 | $733.29M derived: sum of 3 quarters · filed 2021-02-12 | $981.60M derived: sum of 4 quarters · filed 2021-02-12 |
| 2018-12-31 | $249.03M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | $488.83M derived: sum of 2 quarters · filed 2021-02-12 | $737.14M derived: sum of 3 quarters · filed 2021-02-12 | $971.70M 10-K · filed 2021-02-12 |
| 2018-09-30 | $239.81M 10-Q · filed 2019-10-31 | $488.12M derived: sum of 2 quarters · filed 2019-10-31 | $722.67M 10-Q · filed 2019-10-31 | $956.32M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-06-30 | $248.31M 10-Q · filed 2019-08-01 | $482.87M 10-Q · filed 2019-08-01 | $716.52M derived: sum of 3 quarters · filed 2020-02-14 | $934.49M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-03-31 | $234.56M 10-Q · filed 2019-05-01 | $468.20M derived: sum of 2 quarters · filed 2020-02-14 | $686.18M derived: sum of 3 quarters · filed 2020-02-14 | $902.40M derived: sum of 4 quarters · filed 2020-02-14 |
| 2017-12-31 | $233.65M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $451.62M derived: sum of 2 quarters · filed 2020-02-14 | $667.85M derived: sum of 3 quarters · filed 2020-02-14 | $871.68M 10-K · filed 2020-02-14 |
| 2017-09-30 | $217.97M 10-Q · filed 2018-11-01 | $434.20M derived: sum of 2 quarters · filed 2018-11-01 | $638.03M 10-Q · filed 2018-11-01 | $840.40M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-06-30 | $216.22M 10-Q · filed 2018-08-01 | $420.06M 10-Q · filed 2018-08-01 | $622.42M derived: sum of 3 quarters · filed 2019-02-15 | $824.00M derived: sum of 4 quarters · filed 2019-02-15 |
| 2017-03-31 | $203.83M 10-Q · filed 2018-05-04 | $406.20M derived: sum of 2 quarters · filed 2019-02-15 | $607.78M derived: sum of 3 quarters · filed 2019-02-15 | $813.80M derived: sum of 4 quarters · filed 2019-02-15 |
| 2016-12-31 | $202.37M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | $403.95M derived: sum of 2 quarters · filed 2019-02-15 | $609.97M derived: sum of 3 quarters · filed 2019-02-15 | $799.99M 10-K · filed 2019-02-15 |
| 2016-09-30 | $201.58M 10-Q · filed 2017-10-31 | $407.60M derived: sum of 2 quarters · filed 2017-10-31 | $597.62M 10-Q · filed 2017-10-31 | $779.61M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | $206.03M 10-Q · filed 2017-08-01 | $396.04M 10-Q · filed 2017-08-01 | $578.03M derived: sum of 3 quarters · filed 2018-02-16 | $760.14M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | $190.01M 10-Q · filed 2017-04-28 | $372.00M derived: sum of 2 quarters · filed 2018-02-16 | $554.12M derived: sum of 3 quarters · filed 2018-02-16 | $734.70M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | $181.99M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | $364.10M derived: sum of 2 quarters · filed 2018-02-16 | $544.69M derived: sum of 3 quarters · filed 2018-02-16 | $711.62M 10-K · filed 2018-02-16 |
| 2015-09-30 | $182.11M 10-Q · filed 2016-11-01 | $362.70M derived: sum of 2 quarters · filed 2016-11-01 | $529.63M 10-Q · filed 2016-11-01 | $699.43M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | $180.59M 10-Q · filed 2016-08-02 | $347.52M 10-Q · filed 2016-08-02 | $517.31M derived: sum of 3 quarters · filed 2017-02-17 | $687.50M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | $166.93M 10-Q · filed 2016-04-29 | $336.73M derived: sum of 2 quarters · filed 2017-02-17 | $506.91M derived: sum of 3 quarters · filed 2017-02-17 | $678.52M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | $169.79M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $339.98M derived: sum of 2 quarters · filed 2017-02-17 | $511.58M derived: sum of 3 quarters · filed 2017-02-17 | $669.69M 10-K · filed 2017-02-17 |
| 2014-09-30 | $170.19M 10-Q · filed 2015-10-28 | $341.79M derived: sum of 2 quarters · filed 2015-10-28 | $499.90M 10-Q · filed 2015-10-28 | $665.30M derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-06-30 | $171.60M 10-Q · filed 2015-07-30 | $329.71M 10-Q · filed 2015-07-30 | $495.12M derived: sum of 3 quarters · filed 2016-02-17 | $647.63M derived: sum of 4 quarters · filed 2016-02-17 |
| 2014-03-31 | $158.11M 10-Q · filed 2015-04-28 | $323.51M derived: sum of 2 quarters · filed 2016-02-17 | $476.03M derived: sum of 3 quarters · filed 2016-02-17 | $630.91M derived: sum of 4 quarters · filed 2016-02-17 |
| 2013-12-31 | $165.41M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-17 | $317.92M derived: sum of 2 quarters · filed 2016-02-17 | $472.81M derived: sum of 3 quarters · filed 2016-02-17 | $620.94M 10-K · filed 2016-02-17 |
| 2013-09-30 | $152.51M 10-Q · filed 2014-10-24 | $307.40M derived: sum of 2 quarters · filed 2014-10-24 | $455.53M 10-Q · filed 2014-10-24 | $606.02M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-06-30 | $154.88M 10-Q · filed 2014-07-25 | $303.02M 10-Q · filed 2014-07-25 | $453.50M derived: sum of 3 quarters · filed 2015-02-17 | $598.35M derived: sum of 4 quarters · filed 2015-02-17 |
| 2013-03-31 | $148.13M 10-Q · filed 2014-04-25 | $298.62M derived: sum of 2 quarters · filed 2015-02-17 | $443.46M derived: sum of 3 quarters · filed 2015-02-17 | $594.42M derived: sum of 4 quarters · filed 2015-02-17 |
| 2012-12-31 | $150.49M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-17 | $295.33M derived: sum of 2 quarters · filed 2015-02-17 | $446.29M derived: sum of 3 quarters · filed 2015-02-17 | $594.19M 10-K · filed 2015-02-17 |
| 2012-09-30 | $144.84M 10-Q · filed 2013-10-22 | $295.80M derived: sum of 2 quarters · filed 2013-10-22 | $443.70M 10-Q · filed 2013-10-22 | $592.02M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-06-30 | $150.96M 10-Q · filed 2013-07-23 | $298.86M 10-Q · filed 2013-07-23 | $447.18M derived: sum of 3 quarters · filed 2014-02-18 | $589.47M derived: sum of 4 quarters · filed 2014-02-18 |
| 2012-03-31 | $147.90M 10-Q · filed 2013-04-23 | $296.22M derived: sum of 2 quarters · filed 2014-02-18 | $438.51M derived: sum of 3 quarters · filed 2014-02-18 | $582.34M derived: sum of 4 quarters · filed 2014-02-18 |
| 2011-12-31 | $148.32M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-18 | $290.61M derived: sum of 2 quarters · filed 2014-02-18 | $434.44M derived: sum of 3 quarters · filed 2014-02-18 | $572.18M 10-K · filed 2014-02-18 |
| 2011-09-30 | $142.29M 10-Q · filed 2012-10-19 | $286.12M derived: sum of 2 quarters · filed 2012-10-19 | $423.86M 10-Q · filed 2012-10-19 | $562.85M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-06-30 | $143.83M 10-Q · filed 2012-07-20 | $281.58M 10-Q · filed 2012-07-20 | $420.56M derived: sum of 3 quarters · filed 2013-02-19 | $547.98M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-03-31 | $137.75M 10-Q · filed 2012-04-20 | $276.73M derived: sum of 2 quarters · filed 2013-02-19 | $404.15M derived: sum of 3 quarters · filed 2013-02-19 | $536.35M derived: sum of 4 quarters · filed 2013-02-19 |
| 2010-12-31 | $138.99M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | $266.41M derived: sum of 2 quarters · filed 2013-02-19 | $398.61M derived: sum of 3 quarters · filed 2013-02-19 | $524.77M 10-K · filed 2013-02-19 |
| 2010-09-30 | $127.42M 10-Q · filed 2011-10-21 | $259.62M derived: sum of 2 quarters · filed 2011-10-21 | $385.78M 10-Q · filed 2011-10-21 | $523.19M derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-06-30 | $132.20M 10-Q · filed 2011-07-22 | $258.36M 10-Q · filed 2011-07-22 | $395.77M derived: sum of 3 quarters · filed 2012-02-17 | $524.41M derived: sum of 4 quarters · filed 2012-02-17 |
| 2010-03-31 | $126.16M 10-Q · filed 2011-04-21 | $263.57M derived: sum of 2 quarters · filed 2012-02-17 | $392.21M derived: sum of 3 quarters · filed 2012-02-17 | $519.49M derived: sum of 4 quarters · filed 2012-02-17 |
| 2009-12-31 | $137.40M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-17 | $266.05M derived: sum of 2 quarters · filed 2012-02-17 | $393.33M derived: sum of 3 quarters · filed 2012-02-17 | $505.35M 10-K · filed 2012-02-17 |
| 2009-09-30 | $128.64M 10-Q · filed 2010-10-22 | $255.93M derived: sum of 2 quarters · filed 2010-10-22 | $367.95M 10-Q · filed 2010-10-22 | |
| 2009-06-30 | $127.28M 10-Q · filed 2010-07-23 | $239.31M 10-Q · filed 2010-07-23 | ||
| 2008-12-31 | $494.26M 10-K · filed 2011-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |